XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues:        
Premiums $ 25,108 $ 21,260 $ 49,460 $ 42,891
Net investment income 274 146 608 314
Total revenues 88,921 80,636 174,199 157,462
Operating costs:        
Cost of products sold 53,536 49,290 104,991 94,799
Health care costs 21,782 17,490 42,230 35,413
Restructuring charge 496 0 496 0
Opioid litigation charge 0 0 0 484
Loss on assets held for sale 0 0 349 41
Operating expenses 9,873 9,187 19,453 18,511
Total operating costs 85,687 75,967 167,519 149,248
Operating income 3,234 4,669 6,680 8,214
Interest expense 686 583 1,275 1,169
Other income (22) (43) (44) (85)
Income before income tax provision 2,570 4,129 5,449 7,130
Income tax provision 656 1,090 1,393 1,736
Net income 1,914 3,039 4,056 5,394
Net income attributable to noncontrolling interests (13) (10) (19) (11)
Net income attributable to CVS Health $ 1,901 $ 3,029 $ 4,037 $ 5,383
Net income per share attributable to CVS Health:        
Basic (in dollars per share) $ 1.48 $ 2.31 $ 3.15 $ 4.10
Diluted (in dollars per share) $ 1.48 $ 2.29 $ 3.13 $ 4.06
Weighted average shares outstanding:        
Basic (in shares) 1,283 1,313 1,283 1,312
Diluted (in shares) 1,287 1,321 1,289 1,325
Dividends declared per share (in dollars per share) $ 0.605 $ 0.55 $ 1.21 $ 1.10
Cost, Product and Service [Extensible List] Products Products Products Products
Products        
Revenues:        
Revenues $ 60,539 $ 56,794 $ 118,686 $ 109,316
Services        
Revenues:        
Revenues $ 3,000 $ 2,436 $ 5,445 $ 4,941